PolyPid (US: PYPD) — Healthcare · Share Price, Chart & Market Data
About: PolyPid Ltd., a biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. The company is also developing OncoPLEX, which is in preclinical stage for the treatment of intra-tumoral cancer. The company has a research and development collaboration with ImmunoGenesis, Inc. for the development of formulations to treat solid tumors. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.
Sector: Healthcare
Industry: Biotechnology
Latest price: $4.62 (-0.43%)
PYPDPolyPid
Loading watchlist status…
Trade PYPD now
PolyPid share price
PYPD price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 10:47 am GMT+0
PYPD price performance
1.762%
5D
7.944%
1M
6.207%
YTD
83.698%
1Y
PYPD price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 10:47 am GMT+0
PYPD details
PYPD Market Signals